1. STIVARGA Prescribing Information, February 2013.2. Joensuu H. Gastrointestinal stromal tumor (GIST). Annals of Oncology. 2006 September; Volume 17. Available at http://annonc.oxfordjournals.org/content/17/suppl_10/x280.full.pdf+html . Accessed October 19, 2012. 3. American Cancer Society. Gastrointestinal Stromal Tumor (GIST). (Last Revised 2/1/2012). Available at http://www.cancer.org/acs/groups/cid/documents/webcontent/003103-pdf.pdf. Accessed October 12, 2012. 4. Casali, et al. Clinical benefit with regorafenib across subgroups and post progression in patients with advanced gastrointestinal stromal tumors (GIST) after progression on imatinib (IM) and sunitinib (SU): Phase III GRID trial update. 2012 European Society of Medical Oncology; September, 2012. Vienna, Austria. SOURCE Bayer HealthCare Pharmaceuticals Inc.